These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24262354)

  • 41. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
    Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
    J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left ventricular assist devices.
    Birks EJ
    Heart; 2010 Jan; 96(1):63-71. PubMed ID: 19617213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.
    Butler CR; Jugdutt BI
    Heart Fail Rev; 2012 Sep; 17(4-5):615-33. PubMed ID: 22258830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device.
    Khan T; Levin HR; Oz MC; Katz SD
    J Heart Lung Transplant; 1997 Apr; 16(4):449-53. PubMed ID: 9154956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Left ventricular assist devices (LVAD): optional treatment alternative to cardiac transplantation?].
    Wohlschlaeger J; Kawaguchi N; Levkau B; Schmid C; Scheld HH; Baba HA
    Verh Dtsch Ges Pathol; 2004; 88():113-21. PubMed ID: 16892541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful weaning of a left ventricular assist device implanted for ischemic heart failure.
    Beurtheret S; Mordant P; Pavie A; Leprince P
    Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):507-9. PubMed ID: 20650956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac recovery during mechanical assist device support.
    Maybaum S; Kamalakannan G; Murthy S
    Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left ventricular assist device recovery: does duration of mechanical support matter?
    Pham BN; Chaparro SV
    Heart Fail Rev; 2019 Mar; 24(2):237-244. PubMed ID: 30302658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Similar left and right ventricular sarcomere structure after support with a left ventricular assist device suggests the utility of right ventricular biopsies to monitor left ventricular reverse remodeling.
    de Jonge N; Lahpor JR; van Wichen DF; Kirkels H; Gmelig-Meyling FH; van den Tweel JG; Doevendans PA; de Weger RA
    Int J Cardiol; 2005 Feb; 98(3):465-70. PubMed ID: 15708181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left ventricular assist device-induced reverse ventricular remodeling.
    Burkhoff D; Holmes JW; Madigan J; Barbone A; Oz MC
    Prog Cardiovasc Dis; 2000; 43(1):19-26. PubMed ID: 10935554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Large animal models for left ventricular assist device research and development.
    Monreal G; Sherwood LC; Sobieski MA; Giridharan GA; Slaughter MS; Koenig SC
    ASAIO J; 2014; 60(1):2-8. PubMed ID: 24270232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
    Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
    J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature.
    Ton VK; Vunjak-Novakovic G; Topkara VK
    Expert Rev Med Devices; 2016 Nov; 13(11):1029-1034. PubMed ID: 27685648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation.
    Scherer M; Sirat AS; Moritz A; Martens S
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):939-44; discussion 944. PubMed ID: 21071240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenetic basis of myocardial dysfunction and amenability to reversal.
    Garg S; Narula J
    Cardiol Clin; 2003 Feb; 21(1):83-91. PubMed ID: 12790047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elective bridging to recovery after repair: the surgical approach to ventricular reverse remodeling.
    Pitsis AA; Visouli AN; Ninios V; Bougioukas G; Filippatos G; Kremastinos D; Burkhoff D; Long JW
    Artif Organs; 2008 Sep; 32(9):730-5. PubMed ID: 18684205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.